These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11733232)

  • 1. Topical ketorolac after cataract surgery.
    Kaiser CJ
    Ophthalmology; 2001 Dec; 108(12):2152. PubMed ID: 11733232
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
    Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
    Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Akpek EK; Karadayi K
    Am J Ophthalmol; 1999 Nov; 128(5):662-3. PubMed ID: 10577550
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
    Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
    Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED; Perry HD; Wittpenn JR; Solomon R; Nattis A; Chou T
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.
    Price MO; Price FW
    Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
    Solomon KD; Turkalj JW; Whiteside SB; Stewart JA; Apple DJ
    Arch Ophthalmol; 1997 Sep; 115(9):1119-22. PubMed ID: 9298051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR; Johnson D; Hollands H; Smallman D; Baxter S; Eng KT; Kratky V; ten Hove MW; Sharma S; El-Defrawy S
    J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG; Lira RP; Zanetti FR; Machado MC; Rodrigues GB; Arieta CE
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS; Topping TM; Baumann W; Dirks MS; Chern S
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are topical NSAIDs needed for routine cataract surgery?
    Kim A; Stark WJ
    Am J Ophthalmol; 2008 Oct; 146(4):483-5. PubMed ID: 18804560
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.
    Schechter BA
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):507-11. PubMed ID: 18433352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S; Baskaran P; Talwar B; Venkatesh R
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):216-20. PubMed ID: 26225780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.